Globally, 800 women die each day from preventable pregnancy and childbirth complications. This article presents the latest data on key health outcomes, market trends, and the significant economic costs of women's health conditions.
Key Takeaways
- 13% of maternal deaths are due to unsafe abortion, globally
- 800 women die each day from preventable causes related to pregnancy and childbirth
- 29% of women worldwide are affected by anemia
- $24.9 billion global women's health market size in 2023, projected to reach $40.0 billion by 2030
- $6.0 billion global endometriosis therapeutics market size in 2023, projected to reach $10.5 billion by 2030
- $1.8 billion global overactive bladder drugs market size in 2023
- 62% of women with personal health devices (smartwatch/fitness tracker) reported using them at least weekly (survey year 2023)
- 41% of women in the UK used wearables to track their health at least once (survey year 2022)
- 37% of women in Canada have used online appointment booking for medical services (survey year 2021)
- One in 10 women in the US has endometriosis (estimate includes undiagnosed cases)
- In 2022, 332,370 new breast cancer cases were estimated in the US
- In 2022, 19,880 new ovarian cancer cases were estimated in the US
- In the US, the economic burden of intimate partner violence against women was estimated at $3.1 trillion over 2018–2022 (JAMA/CDC cited estimate)
- $4.0 billion annual US cost for pelvic inflammatory disease (estimate)
- US direct medical costs for maternal and newborn care were $372 billion in 2021 (Truven/US estimate referenced by AHRQ)
Pregnancy and violence risks, plus rising women’s health conditions, cost billions and demand better care worldwide.
Related reading
01 · Category
Health Outcomes7 stats
01
13% of maternal deaths are due to unsafe abortion, globally
02
800 women die each day from preventable causes related to pregnancy and childbirth
03
29% of women worldwide are affected by anemia
04
2.7 million adolescents aged 15–19 give birth every year, accounting for the majority of births among adolescent girls
05
1 in 3 women worldwide experience physical and/or sexual intimate partner violence or non-partner sexual violence in their lifetime
06
1 in 5 women in the US will experience a mental health condition in a given year (depression, anxiety, PTSD, etc.)
07
16% of women aged 18–29 in the US reported experiencing serious psychological distress in 2021–2022
Interpretation
Health Outcomes Interpretation
Health outcomes for women remain sharply adverse, with 800 deaths each day tied to pregnancy and childbirth and 29% affected by anemia, while risks also extend beyond childbirth to unsafe abortion and intimate partner violence affecting 1 in 3 women.
02 · Category
Market Size8 stats
01
$24.9 billion global women's health market size in 2023, projected to reach $40.0 billion by 2030
02
$6.0 billion global endometriosis therapeutics market size in 2023, projected to reach $10.5 billion by 2030
03
$1.8 billion global overactive bladder drugs market size in 2023
04
$6.1 billion global maternal and neonatal monitoring devices market in 2023, projected to reach $13.3 billion by 2032
05
$3.4 billion global menopause management market size in 2023
06
$5.0 billion global women's health diagnostics market size in 2023
07
$1.1 billion global pelvic floor disorder treatment market size in 2023
08
$13.1 billion global obstetrics and gynecology devices market size in 2023
Interpretation
Market Size Interpretation
The women’s health market is set to expand rapidly, with the overall market rising from $24.9 billion in 2023 to $40.0 billion by 2030, reinforcing that this category is growing faster than many specific subsegments like menopause management at $3.4 billion in 2023 and endometriosis therapeutics at $6.0 billion in 2023.
03 · Category
User Adoption3 stats
01
62% of women with personal health devices (smartwatch/fitness tracker) reported using them at least weekly (survey year 2023)
02
41% of women in the UK used wearables to track their health at least once (survey year 2022)
03
37% of women in Canada have used online appointment booking for medical services (survey year 2021)
Interpretation
User Adoption Interpretation
User adoption is steadily building, with women most consistently engaging weekly through personal health devices, at 62% in 2023, while broader digital health behaviors like wearables use reach 41% in the UK and online appointment booking stands at 37% in Canada.
More related reading
04 · Category
Industry Trends7 stats
01
One in 10 women in the US has endometriosis (estimate includes undiagnosed cases)
02
In 2022, 332,370 new breast cancer cases were estimated in the US
03
In 2022, 19,880 new ovarian cancer cases were estimated in the US
04
In 2022, 43,720 new cervical cancer cases were estimated in the US
05
The US FDA approved 54 new drugs in 2023; women accounted for 51% of trial participants in new drug applications (FDA analysis)
06
The FDA required 2,169 clinical trials to include women and minorities across certain approvals (FDA report)
07
WHO estimates 1.1 million women worldwide are living with HIV and need sustained care
Interpretation
Industry Trends Interpretation
Industry Trends show that women’s health challenges remain widespread and urgently targeted, with 1 in 10 women in the US estimated to have endometriosis alongside tens of thousands of new breast, ovarian, and cervical cancer cases each year, while regulators also push for better representation with women making up 51% of trial participants in 54 FDA-approved new drugs in 2023 and 2,169 clinical trials required to include women and minorities.
05 · Category
Cost Analysis7 stats
01
In the US, the economic burden of intimate partner violence against women was estimated at $3.1 trillion over 2018–2022 (JAMA/CDC cited estimate)
02
$4.0 billion annual US cost for pelvic inflammatory disease (estimate)
03
US direct medical costs for maternal and newborn care were $372 billion in 2021 (Truven/US estimate referenced by AHRQ)
04
HPV-related cancers cost the US healthcare system about $7.4 billion per year (estimate)
05
$9.1 billion annual economic burden of uterine fibroids in the US (estimate)
06
$15.2 billion annual cost of osteoporosis in the US (2019 estimate)
07
$2.7 billion direct medical costs of urinary tract infections in the US (2019 estimate)
Interpretation
Cost Analysis Interpretation
Across the US, womens health conditions drive enormous and wide-ranging costs, from $3.1 trillion in estimated economic burden from intimate partner violence over 2018–2022 to more than $15.2 billion per year for osteoporosis, underscoring how major health harms translate into persistent, high overall economic strain.
report visual · Key figures
Key Women’s Health Indicators
Show a focused comparison across major women’s health risks and conditions using globally relevant proportions and the overall scale of pregnancy-related preventable deaths.
13%
13% of maternal deaths are due to unsafe abortion, globally
800
800 women die each day from preventable causes related to pregnancy and childbirth
29%
29% of women worldwide are affected by anemia
1
1 in 3 women worldwide experience physical and/or sexual intimate partner violence or non-partner sexual violence in the
16%
16% of women aged 18–29 in the US reported experiencing serious psychological distress in 2021–2022
10
One in 10 women in the US has endometriosis (estimate includes undiagnosed cases)
source-verifiedwho.int · samhsa.gov · womenshealth.gov2021
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Marcus Afolabi. (2026, February 13). Womens Health Statistics. Gitnux. https://gitnux.org/womens-health-statistics
MLA
Marcus Afolabi. "Womens Health Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/womens-health-statistics.
Chicago
Marcus Afolabi. 2026. "Womens Health Statistics." Gitnux. https://gitnux.org/womens-health-statistics.
Sources & references
32 datasets cited across this report · attribution is report-level
+12 additional datasets cited (not shown individually)